Announces developments in its Phase I/II clinical trial investigating a novel treatment for Type 1 Diabetes ...
/CNW/ - Sernova Corp. ("Sernova" or the "Company") (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH) is pleased to announce that it has filed a preliminary short form...
Monday U.S. Featured Earnings Nucor Corporation (NYSE:NUE) (Q4) EPS of $2.83, compared ...
Announced the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug Designation (ODD) ...
Announced an update on its conformal coating immune protection technology program, that is used in combination ...
Today presented interim positive results from its ongoing Phase 1/2 clinical trial investigating islet ...
Announced it will host two investor and analyst conference calls, with corresponding live webcasts. ...
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2022 annual report on Form 20-F with the U.S. Securities...
/CNW/ - The group of longstanding shareholders (the "Concerned Shareholders") of Sernova Corp (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH) (XETRA: PSH) ("Sernova" or...
Reminds shareholders to vote the WHITE management proxy in advance of the proxy voting deadline on Tuesday ...